Globe Life (GL) to Release Earnings on Wednesday

Globe Life (NYSE:GL - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of $3.23 per share and revenue of $1.49 billion for the quarter. Globe Life has set its FY 2025 guidance at 13.450-14.050 EPS.

Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $3.14 EPS for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Globe Life Stock Performance

GL stock opened at $121.50 on Wednesday. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market cap of $10.11 billion, a PE ratio of 10.17 and a beta of 0.60. The business has a 50 day moving average of $124.11 and a 200-day moving average of $115.95. Globe Life has a 12-month low of $66.25 and a 12-month high of $133.76.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Thursday, April 3rd will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend is Thursday, April 3rd. This is an increase from Globe Life's previous quarterly dividend of $0.24. Globe Life's dividend payout ratio is 9.04%.

Wall Street Analysts Forecast Growth

GL has been the topic of a number of research analyst reports. BMO Capital Markets initiated coverage on shares of Globe Life in a report on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 price target on the stock. Wells Fargo & Company dropped their target price on shares of Globe Life from $141.00 to $140.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Keefe, Bruyette & Woods increased their target price on shares of Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research report on Wednesday, February 12th. Morgan Stanley lowered their price target on shares of Globe Life from $126.00 to $117.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. Finally, Piper Sandler increased their price objective on Globe Life from $140.00 to $152.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Four investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $137.55.

Insider Buying and Selling at Globe Life

In other news, CEO James Matthew Darden sold 24,890 shares of Globe Life stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total value of $3,024,632.80. Following the completion of the transaction, the chief executive officer now directly owns 38,973 shares in the company, valued at approximately $4,735,998.96. The trade was a 38.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 11,000 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $122.31, for a total value of $1,345,410.00. Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at $2,317,529.88. This trade represents a 36.73 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.51% of the company's stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.